CAJ | 학술논문

目的观察柳氮磺吡啶结肠溶胶囊联合云南白药治疗轻、中度溃疡性结肠炎的临床疗效。方法选取轻、中度溃疡性结肠炎患者60例，随机分为治疗组与对照组各30例。治疗组口服柳氮磺吡啶结肠溶胶囊及云南白药，对照组仅口服柳氮磺吡啶结肠溶胶囊。结果治疗组总有效率为90.0％，临床治愈率为73.3％；对照组总有效率为66.7％，临床治愈率为43.3％，两组差异均有统计学意义（均P＜0.05）。结论柳氮磺吡啶结肠溶胶囊联合云南白药治疗治疗轻、中度溃疡性结炎具有较好的临床疗效。
목적 관찰류담광필정결장용효낭연합운남백약치료경、중도궤양성결장염적림상료효。방법 선취경、중도궤양성결장염환자60례，수궤분위치료조여대조조각30례。치료조구복류담광필정결장용효낭급운남백약，대조조부구복류담광필정결장용효낭。결과 치료조총유효솔위90.0％，림상치유솔위73.3％；대조조총유효솔위66.7％，림상치유솔위43.3％，량조차이균유통계학의의（균P＜0.05）。결론 류담광필정결장용효낭연합운남백약치료치료경、중도궤양성결염구유교호적림상료효。
Objective To evaluate the clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis. Methods Sixty patients with ulcerative colitis were randomly divided into two groups,thirty cases in treatment group and thirty cases in control group. Patients in treatment group received sulfasalazine capsulae enterosolubilis with Ytmnanbaiyao orally,patients in control group were given sulfasalazine capsulae enterosolubilis orally only. Results The total effective rate of treatment group was 90. 0％ ,clinical recovery rate was 73.3％ ;The total effective rate of control group was 66.7％ ,clinical recovery rate was 43.3％ ,the differences was statistically significant(P ＜0.05). Conclusion The clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis was good,and should be used furthedy.